stoxline Quote Chart Rank Option Currency Glossary
  
ARS Pharmaceuticals, Inc. (SPRY)
8.85  0.04 (0.45%)    02-13 16:00
Open: 8.91
High: 9.18
Volume: 2,090,474
  
Pre. Close: 8.81
Low: 8.61
Market Cap: 875(M)
Technical analysis
2026-02-13 4:47:20 PM
Short term     
Mid term     
Targets 6-month :  13.33 1-year :  15.35
Resists First :  11.41 Second :  13.14
Pivot price 9.89
Supports First :  8.6 Second :  7.16
MAs MA(5) :  9.37 MA(20) :  10.03
MA(100) :  9.96 MA(250) :  12.39
MACD MACD :  -0.5 Signal :  -0.3
%K %D K(14,3) :  11.3 D(3) :  15.9
RSI RSI(14): 35.1
52-week High :  18.89 Low :  6.65
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ SPRY ] has closed below the lower bollinger band by 2.7%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 15.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.19 - 9.24 9.24 - 9.29
Low: 8.48 - 8.54 8.54 - 8.6
Close: 8.75 - 8.85 8.85 - 8.94
Company Description

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.

Headline News

Tue, 10 Feb 2026
ARS Pharmaceuticals to Showcase Scientific Innovation and - GlobeNewswire

Mon, 02 Feb 2026
Needle-free allergy rescue for kids wins key EU support - Stock Titan

Sat, 31 Jan 2026
Lisanti Capital Growth LLC Sells 208,886 Shares of ARS Pharmaceuticals, Inc. $SPRY - MarketBeat

Sat, 10 Jan 2026
Assessing ARS Pharmaceuticals (SPRY) Valuation After A 19.3% Single Day Share Price Jump - Yahoo Finance

Fri, 09 Jan 2026
ARS Pharma (SPRY) Gains China Approval for Neffy, Roth Reiterates Buy Rating - Yahoo Finance

Mon, 10 Nov 2025
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 99 (M)
Held by Insiders 1.0541e+008 (%)
Held by Institutions 16.8 (%)
Shares Short 21,590 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -8.981e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -56.1 %
Operating Margin -163.7 %
Return on Assets (ttm) -19.3 %
Return on Equity (ttm) -46 %
Qtrly Rev. Growth 1 %
Gross Profit (p.s.) 637.29
Sales Per Share 1.92932e+008
EBITDA (p.s.) 1.5523e+008
Qtrly Earnings Growth -0.9 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -85 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 4.39
Stock Dividends
Dividend 0
Forward Dividend 2.022e+007
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android